Post-infective transverse myelitis following Streptococcus pneumoniae meningitis with radiological features of acute disseminated encephalomyelitis: a case report
© Williams and Thorpe; licensee BioMed Central Ltd. 2012
Received: 1 May 2012
Accepted: 19 July 2012
Published: 19 September 2012
Post-infectious autoimmune demyelination of the central nervous system is a rare neurological disorder typically associated with exanthematous viral infections. We report an unusual presentation of the condition and a previously undocumented association with Streptococcus pneumonia meningitis.
A 50-year-old Caucasian woman presented to our facility with an acute myelopathy three days after discharge following acute Streptococcus pneumoniae meningitis. Imaging studies of the spine ruled out an infective focus and no other lesions were seen within the cord. Diffuse, bilateral white matter lesions were seen within the cerebral hemispheres, and our patient was diagnosed as having a post-infective demyelination syndrome that met the diagnostic criteria for an acute transverse myelitis. Our patient clinically and radiologically improved following treatment with steroids.
The novel association of a Streptococcus pneumoniae infection with post-infectious autoimmune central nervous system demyelination should alert the reader to the potentially causative role of this common organism, and gives insights into the pathogenesis. The unusual dissociation between the clinical presentation and the location of the radiological lesions should also highlight the potential for the condition to mimic the presentation of others, and stimulates debate on the definitions of acute transverse myelitis and acute disseminated encephalomyelitis, and their potential overlap.
KeywordsPost-infective demyelination Transverse myelitis Acute disseminated encephalomyelitis Pneumococcal meningitis Streptococcus pneumoniae
Diagnostic criteria for acute transverse myelitis
Disease associated features
Development of sensory, motor or autonomic dysfunction attributable to the spinal cord
History of spinal irradiation in the last 10 years
Serological or clinical evidence of a systemic autoimmune disorder
Bilateral signs and/or symptoms (not necessarily symmetrical)
Clear arterial distribution of the clinical deficit suggesting anterior spinal artery thrombosis
Central nervous system (CNS) manifestation of syphilis, Lyme disease, HIV, human T-lymphotropic virus 1 (HTLV-1), mycoplasma, other viral infections
Exclusion of extra-axial compressive etiology by magnetic resonance imaging (MRI) or myelography
Abnormal flow void on the surface of the spinal cord consistent with arteriovenous malformation
Abnormalities on brain MRI scans suggestive of multiple sclerosis (MS) or acute disseminated encephalomyelitis (ADEM)
Inflammation within the spinal cord demonstrated by cerebrospinal fluid (CSF) pleocytosisor elevated IgG index or gadolinium enhancement
History of clinically apparent optic neuritis
Peak severity reached between four hours and 21 days after onset
ADEM is a predominantly paediatric disease, where it has an incidence of 0.4 to 0.8 per 100,000. It is even more rare in adults, where it has a mean age of onset of 32 to 51 years . It typically presents with focal neurological signs and encephalopathy; due to the disseminated and variable location of involvement within the central nervous system (CNS), such focal lesions can include motor, sensory, cranial nerve, brainstem or cerebellar signs. Its mechanism is autoimmune, resulting in multifocal demyelination of the CNS, with relative preservation of axons. These foci are mainly in supratentorial white matter, and are pathologically characterised by their perivenous distribution . The thalamus, basal ganglia, cerebellum and spinal cord can also be involved . Differentiating ADEM from a clinically isolated syndrome of multiple sclerosis is often challenging. In contrast to multiple sclerosis, however, the lesions seen in ADEM on MRI are not sharply delineated, and are often very large or confluent . The temporal association with infections and, less commonly, vaccinations, insect stings and immunoglobulin administration has led to our current theories of pathogenesis: antigenic mimicry between pathogenic antigens and myelin epitopes; activation of clonal populations of autoreactive T-cells; suppression of CD4+ T-cells; and stimulation of major histocompatibility II molecule expression in astrocytes and microglia have all been suggested, and it is unlikely that such mechanisms would be mutually exclusive .
In order to improve consistency and accuracy in the diagnosis of and research into ADEM, definitions were produced by the International Pediatric MS Study Group . It was emphasised that the diagnosis of ADEM must rest upon the clinical features of an acute or subacute onset of multifocal features representing involvement of different areas of the CNS, together with encephalopathy (defined as behavioural change or alteration in consciousness). The definition also requires MRI features, typically large multifocal or unifocal lesions within the white matter of the brain and/or spinal cord, as described above. Importantly, however, it is suggested that the diagnosis of ADEM cannot be made based upon radiological features alone.
Although the above definition was intended for use only within the paediatric group (age <10 years), it has been applied to adult cases of ADEM. Young et al. demonstrated that in a cohort of 13 patients (mean age 43 years) with ADEM diagnoses based upon the pathological hallmark of perivascular demyelination demonstrated on biopsy and/or autopsy, encephalopathy or reduced level of consciousness was seen significantly more often compared to a larger cohort (n=91) showing confluent demyelination (the hallmark of MS P <0.001) . Although a small study, this appears to lend support to the International Pediatric MS Study Group’s emphasis upon clinical presentation, and suggests that it may also be applied to adults.
A 50-year-old, previously well Caucasian woman with a one-week history of flu-like symptoms and three days of purulent exudate from both ears presented to our facility with vomiting, collapse and reduced conscious level. Investigations confirmed a diagnosis of acute Streptococcus pneumoniae meningitis secondary to otitis media. Our patient was treated on an intensive care ward, requiring sedation and intubation. Initial treatment was with intravenous amoxicillin and acyclovir, later switching to ceftriaxone. Our patient made a slow but uneventful recovery, leaving intensive care after six days, and being discharged a further five days later.
Our patient reported gradually increasing lower limb weakness at home, and on the third day post-discharge she was readmitted following a fall. On admission she was fully conscious but paraparetic, with impaired sensation in her lower limbs and painless urinary retention. On examination she was apyrexial, with normal fundi, cranial nerves and upper limbs. Examination of the lower limbs revealed slightly reduced tone, a pyramidal pattern of weakness, moderately brisk reflexes and bilateral extensor plantars. A sensory level was present at T10.
Initial investigations revealed a mild neutrophilic leukocytosis. Other routine blood test results were normal.
CSF analysis revealed a lymphocytic pleocytosis (12 polymorphs, 96 lymphocytes and 22 red blood cells per mm3), a raised protein level (1.84g/L, normal <0.4g/L) and normal glucose level. No oligoclonal bands or organisms were found, virology screen results were negative, and no organisms were cultured.
Having excluded a septic focus and sinus thrombosis, on the basis of the MRI scan appearance, a diagnosis of post-infective demyelination that met the diagnostic criteria of an acute transverse myelitis was made. Our patient received a three-day course of methylprednisolone (1g/day intravenously), followed by oral prednisolone (60mg/day). Repeated imaging of the brain 10 days after readmission showed that the lesions were beginning to resolve. Her power began to improve and she was discharged four weeks after her readmission. Significant recovery was achieved by four months, but with residual deficits: walking was limited to 500 metres unaided, with a spastic gait and mild pyramidal weakness and hyper-reflexia of the lower limbs. There were no further neurological events over the ensuing year by which time she was able to walk two miles but had evidence of a mild residual spastic paraparesis.
We report an unusual case of post-infectious demyelination. The diagnosis was initially slightly tentative based on the presentation of an acute spinal cord syndrome associated with suggestive brain lesions on MRI scan despite a causative cord lesion not being visualised. Initially it seemed more likely that our patient had a pyogenic abscess or conceivably venous sinus thrombosis but these were excluded by appropriate imaging. The response to steroids provided further support for the diagnosis.
Our patient met the Transverse Myelitis Consortium Working Group’s criteria  for ATM due to the appropriate clinical presentation, evidence of inflammation within the spinal cord obtained on CSF analysis, and exclusion of other aetiologies; it is worth highlighting that the criteria state that evidence of inflammation on CSF analysis alone, in the absence of radiological features, is sufficient to support the diagnosis. Due to the abnormal brain imaging, however, it could be classified as a disease-associated ATM, with MS, a CIS or ADEM suspected as the underlying pathological process. There were no features of a systemic connective tissue disease.
Post-infectious ATM is a well-recognised phenomenon. It can also occur following vaccinations, and in both cases it is thought that the mechanism involves a breakdown of self-tolerance leading to an autoimmune reaction against CNS antigens . It has been suggested that post-infective ATM is a localised form of ADEM [9, 10], and it has also been emphasised that disseminated encephalomyelitis can produce a broad spectrum of pathological and anatomical manifestations . One would expect, however, such cases to be accompanied by evidence of spinal lesions on MRI scans, and such post-infectious or post-vaccination demyelinating disorders of the CNS are usually characterised by multifocal signs and encephalopathy, leading to the diagnosis of ADEM .
As previously discussed, despite the presence of large and confluent lesions without sharp delineation on brain imaging being highly suggestive of a diagnosis of ADEM, such a diagnosis cannot be made based upon radiological criteria alone, and hence it is excluded due to the absence of the clinical features. Our patient did not have a history suggestive of previous demyelination, there was an absence of oligoclonal bands and the imaging would not be typical for a clinically isolated syndrome. It also seems highly unlikely that the temporal association with the meningeal infection was a coincidence.
We were therefore left with our patient meeting the criteria for a disease-associated ATM following pneumococcal meningitis, with normal spinal imaging and brain lesions characteristic of ADEM, but without the clinical features necessary for its diagnosis.
It appears that this case is unusual for a number of reasons. Firstly, to the best of our knowledge, this is the first reported case in the English literature of an S. pneumoniae infection being associated with post-infective autoimmune CNS demyelination. In such conditions, the causal infections are most commonly viral, particularly those causing exanthematous disease (for example, measles, rubella or varicella) . Streptococcal infections have previously been associated with ADEM, though this is limited to the Lancefield group A β-haemolytic species. Such paediatric cases are associated with anti-basal ganglia antibodies and a high incidence of basal ganglial lesions, raising similarities with Sydenham’s chorea and the paediatric autoimmune neuropsychological disorders associated with Streptococcus (PANDAS) . One adult case of post-group A β-haemolytic streptococcal ADEM has been reported, in which there were no basal ganglia lesions .
In contrast to the β-haemolytic species, there have only been two previous Japanese reports of suspected ADEM following α-haemolytic S. pneumoniae infection [15, 16]. There has also been one report of widespread white matter lesions in association with a paediatric case of S. pneumoniae meningitis . In contrast to our patient’s case, however, these occurred very early in the course of the disease, and it was thought that they were likely to represent global ischaemia and cytotoxic oedema secondary to a cerebral vasculitis initiated directly in response to the presence of the pneumococcal antigens. This is in contrast to the proposed mechanisms thought to be causative in the post-infective demyelination of our case, which typically occurs after a delay of a few days to weeks from the initiating infection as a result of direct autoimmune attack of CNS antigens.
The involvement of S. pneumoniae in the initiation of post-infective demyelination has implications for the pathogenesis. Proposed pathogenic mechanisms by which streptococcal infections cause post-infective demyelination include involvement of the mentioned anti-basal ganglia antibodies , and stimulating clonal expansion of anti-myelin T cells via exotoxin superantigens produced by group A β-haemolytic strains . This case therefore highlights not only how pneumococcal infections should be considered in the aetiology of post-infective demyelination, but also, as neither the anti-basal ganglia antibodies nor the superantigenic exotoxins are associated with pneumococcal infections, how a variety of pathological mechanisms must be capable of leading to post-streptococcal demyelination.
The second unusual feature of this case is the apparent overlap between the clinical features of ATM and the radiological features of cerebral ADEM. The precise nature of the lesions is unlikely to be determined; if histological specimens were available, the finding of a perivascular distribution of the demyelination would give a pathological diagnosis of ADEM, lending support to the radiological appearance and suggesting that the absence of encephalopathy is not significant. This could then be classified as ADEM presenting as a disease-associated ATM. Indeed, in a previous study of patients with histologically confirmed ADEM, encephalopathy and depressed level of consciousness were only 77% and 62% sensitive, respectively . In the original consensus definition of ADEM, the International Pediatric MS Study Group also acknowledged that the absolute requirement for encephalopathy may be overly restrictive, but deemed it necessary in order for sufficient specificity .
If this were to be the case, the disparity between clinical and radiological localisation of the lesions would still be unusual for ADEM. Despite our patient’s signs and symptoms pointing to a clinical diagnosis of acute transverse myelitis with a T10 sensory level, imaging revealed lesions limited to the corona radiata. Awareness of this will lead to improved diagnosis, as it highlights how the condition may mimic the presentation of others, and the importance of imaging the whole CNS once the more common differentials have been ruled out.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Dr Nagui Antoun provided advice on and access to the presented imaging.
- Transverse Myelitis Consortium Working Group: Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59: 499-505.View ArticleGoogle Scholar
- Sonneville R, Klein I, de Broucker T, Wolff M: Post-infectious encephalitis in adults: diagnosis and management. J Infect. 2009, 58: 321-328. 10.1016/j.jinf.2009.02.011.View ArticlePubMedGoogle Scholar
- Lassmann H: Acute disseminated encephalomyelitis and multiple sclerosis. Brain. 2010, 133: 317-319. 10.1093/brain/awp342.View ArticlePubMedGoogle Scholar
- Wender M: Acute disseminated encephalomyelitis (ADEM). J Neuroimmunol. 2011, 231: 92-99. 10.1016/j.jneuroim.2010.09.019.View ArticlePubMedGoogle Scholar
- Tselis A, Lisak R: Acute disseminated encephalomyelitis. Clinical Neuroimmunology. 2005, Oxford University Press, Oxford, UK, 147-171. 2Google Scholar
- Krupp LB, Banwell B, Tenembaum S, International Pediatric MS Study Group: Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007, 68: S7-S12. 10.1212/01.wnl.0000259422.44235.a8.View ArticlePubMedGoogle Scholar
- Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, Thomsen KM, Mandrekar JN, Erickson BJ, Lucchinetti CF: Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain. 2010, 133: 333-348. 10.1093/brain/awp321.View ArticlePubMedPubMed CentralGoogle Scholar
- Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y: Transverse myelitis and vaccines: a multi-analysis. Lupus. 2009, 18: 1198-1204. 10.1177/0961203309345730.View ArticlePubMedGoogle Scholar
- AlDeeb SM, Yaqub BA, Bruyn GW, Biary NM: Acute transverse myelitis - a localized form of postinfectious encephalomyelitis. Brain. 1997, 120: 1115-1122. 10.1093/brain/120.7.1115.View ArticleGoogle Scholar
- Ginsberg L: Disorders of the spinal cord and roots. Pract Neurol. 2011, 11: 259-267. 10.1136/practneurol-2011-000069.View ArticlePubMedGoogle Scholar
- Brinar VV, Poser CM: The spectrum of disseminated encephalomyelitis. Clin Neurol Neurosurg. 2006, 108: 295-310. 10.1016/j.clineuro.2005.11.017.View ArticlePubMedGoogle Scholar
- Brinar VV, Habek M, Zadro I, Barun B, Ozretic D, Vranjes D: Current concepts in the diagnosis of transverse myelopathies. Clin Neurol Neurosurg. 2008, 110: 919-927. 10.1016/j.clineuro.2008.07.002.View ArticlePubMedGoogle Scholar
- Dale RC, Church AJ, Cardoso F, Goddard E, Cox TC, Chong WK, Williams A, Klein NJ, Neville BG, Thompson EJ, Giovannoni G: Poststreptococcal acute disseminated encephalomyelitis with basal ganglia involvement and auto-reactive antibasal ganglia antibodies. Ann Neurol. 2001, 50: 588-595. 10.1002/ana.1250.View ArticlePubMedGoogle Scholar
- Ning MM, Smirnakis S, Furie KL, Sheen VL: Adult acute disseminated encephalomyelitis associated with poststreptococcal infection. J Clin Neurosci. 2005, 12: 298-300. 10.1016/j.jocn.2004.03.030.View ArticlePubMedGoogle Scholar
- Ueda M, Kanamori A, Mihara T, Hara H, Mutoh T: A case of acute disseminated encephalomyelitis (ADEM) following treatment for pneumococcal meningoencephalitis [in Japanese]. Rinsho Shinkeigaku. 2009, 49: 96-99. 10.5692/clinicalneurol.49.96.View ArticlePubMedGoogle Scholar
- Ohnishi H, Sawayama Y, Ariyama I, Yamaji K, Furusyo N, Hayashi J: Acute disseminated encephalomyelitis (ADEM) onset during meningitis and sepsis [in Japanese]. Kansenshogaku Zasshi. 2007, 81: 577-581.View ArticlePubMedGoogle Scholar
- Jorens PG, Parizel PM, Wojciechowski M, Laridon A, De Weerdt A, Mertens G, Ceulemans B: Streptococcus pneumoniae meningoencephalitis with unusual and widespread white matter lesions. Eur J Paediatr Neurol. 2008, 12: 127-132. 10.1016/j.ejpn.2007.06.007.View ArticlePubMedGoogle Scholar
- Jorens PG, VanderBorght A, Ceulemans B, Van Bever HP, Bossaert LL, Ieven M, Goossens H, Parizel PM, Van Dijk H, Raus J, Stinissen P: Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology. 2000, 54: 1433-1441. 10.1212/WNL.54.7.1433.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.